Th17细胞在慢性淋巴细胞白血病中的作用:是敌还是友?
本文综述Th17细胞在慢性淋巴细胞白血病(CLL)中的临床意义及其与白血病微环境的相互作用。多项临床报告显示CLL患者Th17细胞和/或白细胞介素17血清细胞因子水平较健康个体升高,并与多种预后标志物及肿瘤微环境显著变化相关。Th17细胞促进CLL进展的确切机制尚待深入研究,靶向治疗对Th17细胞的影响及过继细胞治疗潜力亦有待探索。
要点
- CLL患者Th17细胞和/或白细胞介素17血清水平较健康个体升高,与多种预后标志物相关。
- Th17细胞在肿瘤中可表现为促肿瘤或抗肿瘤活性,取决于不同肿瘤背景。
- Th17细胞促进CLL进展的确切机制尚待深入研究。
核心结论
- 深刻理解Th17细胞在CLL中扮演的角色对于设计实现免疫稳态并最大化临床获益的新型疗法至关重要。
研究设计与样本
- 本文为综述,汇总与Th17细胞在CLL中意义相关的临床信息及其与白血病微环境的相互作用。
主要发现
- 许多临床报告表明,与健康个体相比,CLL患者Th17细胞和/或白细胞介素17血清细胞因子水平升高。
- 上述升高与多种预后标志物及肿瘤微环境的显著变化相关。
- Th17细胞在癌症中可表现为促肿瘤或抗肿瘤活性,取决于不同癌症背景。
- Th17细胞促进CLL进展的确切机制尚待深入研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- Th17细胞促进CLL进展的确切机制尚待深入研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T helper 17 (Th17) cells have a prominent role in autoimmune diseases. In contrast, the nature of these cells in cancer is controversial, with either pro- or antitumorigenic activities depending on various cancer settings. Chronic lymphocytic leukemia (CLL), a B-cell malignancy, is characterized by an imbalance in T-cell immune responses that contributes to disease progression and increased mortality. Many clinical reports indicate an increase in Th17 cells and/or interleukin 17 serum cytokine levels in patients with CLL compared with healthy individuals, which correlates with various prognostic markers and significant changes in the tumor microenvironment. The exact mechanisms by which Th17 cells might contribute to CLL progression remain poorly investigated. In this review, we provide an updated presentation of the clinical information related to the significance of Th17 cells in CLL and their interaction with the complex leukemic microenvironment, including various mediators, immune cells, and nonimmune cells. We also address the available data regarding the effects of CLL-targeted therapies on Th17 cells and the potential of using these cells in adoptive cell therapies. Having a sound understanding of the role played by Th17 cells in CLL is crucial for designing novel therapies that can achieve immune homeostasis and maximize clinical benefits.
引用
- Gamal W, Sahakian E, Pinilla-Ibarz J, et al. The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? Blood Adv. 2023. PMID: 36574293. doi:10.1182/bloodadvances.2022008985
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。